To confirm whether Med14 was an integral link between GLP-1 drugs and ultimate changes in gene expression and pancreatic beta cell behavior, the researchers decided to mutate Med14, making the protein resistant to phosphorylation
Weight cycling deregulates eating behavior via the induction of durable gut dysbiosis. *Advanced Science*, 2025 Centuries of Evidence: Why Diets Dont Work This week on Fat Science, Mark Wright, Andrea Taylor, and Dr
The transcriptional regulator Hbx1 affects the expression of thousands of genes in the aflatoxin-producing fungus Aspergillus flavus
The SELECT trial, published in the New England Journal of Medicine in 2023, demonstrated that semaglutide significantly reduced major adverse cardiovascular events in patients with established cardiovascular disease and overweight or obesity, representing a landmark finding for GLP-1 receptor agonists in cardiovascular risk reduction
Triagonism: Is Three Better than Two
A horse, a jockey, and a therapeutic dilemma: choosing the best option for a patient with diabetes and coronary artery disease